SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

US FDA issues Form 483 with five observations for Cohance Lifesciences's plant

The U.S. Food and Drug Administration (FDA) has issued a Form 483 with five observations for Cohance Lifesciences's manufacturing unit located in Jaggaiahpet, Andhra Pradesh.

COHA.NS

S. FDA issued a Form 483 with five observations for Cohance Lifesciences Ltd’s Jaggaiahpet unit in Andhra Pradesh.